Rosemary Aoko has been buying antiretroviral (ARV) medication for two of her relatives. She found the free medication system too cumbersome, often plagued by stockouts, shortages of preferred drugs, ...
IF PAULA MENDES achieves her goals, her nanotechnology innovations will soon allow doctors to diagnose cancer with greater ...
The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. For instance, in clinical chemistry ...
Researchers have developed an inexpensive blood test that they say can detect pancreatic cancer — even in its early stages.
The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...
According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Troponin, CK-MB ...
According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type ...
Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...
Dr. Gurkan has industry roles in start-up companies as the Director of Technology at BioChip Labs Inc. and Senior Scientist at Hemex Health Inc. BioChip Labs Inc. offers commercial clinical ...
Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan ...
Previously, to earn that mark and be used in diagnostic testing, assays like these had to meet requirements under the In Vitro Diagnostic Directive (IVDD), but more rigorous requirements went into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results